49 related articles for article (PubMed ID: 12124800)
1. Alkaline ceramidase 2 (ACER2) and its product dihydrosphingosine mediate the cytotoxicity of N-(4-hydroxyphenyl)retinamide in tumor cells.
Mao Z; Sun W; Xu R; Novgorodov S; Szulc ZM; Bielawski J; Obeid LM; Mao C
J Biol Chem; 2010 Sep; 285(38):29078-90. PubMed ID: 20628055
[TBL] [Abstract][Full Text] [Related]
2. Clinical development of fenretinide as an antineoplastic drug: Pharmacology perspectives.
Cooper JP; Reynolds CP; Cho H; Kang MH
Exp Biol Med (Maywood); 2017 Jun; 242(11):1178-1184. PubMed ID: 28429653
[TBL] [Abstract][Full Text] [Related]
3. How retinoids regulate breast cancer cell proliferation and apoptosis.
Simeone AM; Tari AM
Cell Mol Life Sci; 2004 Jun; 61(12):1475-84. PubMed ID: 15197471
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative and apoptotic activities of ketonucleosides and keto-C-glycosides against non-small-cell lung cancer cells with intrinsic drug resistance.
Paterson J; Uriel C; Egron MJ; Herscovici J; Antonakis K; Alaoui-Jamali MA
Antimicrob Agents Chemother; 1998 Apr; 42(4):779-84. PubMed ID: 9559782
[TBL] [Abstract][Full Text] [Related]
5. Attempts to Improve Lipophilic Drugs' Solubility and Bioavailability: A Focus on Fenretinide.
Alfei S; Zuccari G
Pharmaceutics; 2024 Apr; 16(5):. PubMed ID: 38794242
[TBL] [Abstract][Full Text] [Related]
6. Cactus pear: a natural product in cancer chemoprevention.
Zou DM; Brewer M; Garcia F; Feugang JM; Wang J; Zang R; Liu H; Zou C
Nutr J; 2005 Sep; 4():25. PubMed ID: 16150152
[TBL] [Abstract][Full Text] [Related]
7. Validated LC-MS/MS Assay for the Quantitative Determination of Fenretinide in Plasma and Tumor and Its Application in a Pharmacokinetic Study in Mice of a Novel Oral Nanoformulation of Fenretinide.
Matteo C; Orienti I; Eramo A; Zeuner A; Ferrari M; Passoni A; Bagnati R; Ponzo M; Bello E; Zucchetti M; Frapolli R
Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543281
[TBL] [Abstract][Full Text] [Related]
8. Updates on Emerging Interventions for Autosomal Recessive
Wang L; Shah SM; Mangwani-Mordani S; Gregori NZ
J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834872
[TBL] [Abstract][Full Text] [Related]
9. Molecular Inverse Comorbidity between Alzheimer's Disease and Lung Cancer: New Insights from Matrix Factorization.
Greco A; Sanchez Valle J; Pancaldi V; Baudot A; Barillot E; Caselle M; Valencia A; Zinovyev A; Cantini L
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31247897
[TBL] [Abstract][Full Text] [Related]
10. Vitamin A, cancer treatment and prevention: the new role of cellular retinol binding proteins.
Doldo E; Costanza G; Agostinelli S; Tarquini C; Ferlosio A; Arcuri G; Passeri D; Scioli MG; Orlandi A
Biomed Res Int; 2015; 2015():624627. PubMed ID: 25879031
[TBL] [Abstract][Full Text] [Related]
11. Inducible expression of tissue factor in small-cell lung cancer: impact on morphology and matrix metalloproteinase secretion.
Hahn N; Heiden M; Seitz R; Salge-Bartels U
J Cancer Res Clin Oncol; 2012 Apr; 138(4):695-703. PubMed ID: 22237453
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group.
Villablanca JG; London WB; Naranjo A; McGrady P; Ames MM; Reid JM; McGovern RM; Buhrow SA; Jackson H; Stranzinger E; Kitchen BJ; Sondel PM; Parisi MT; Shulkin B; Yanik GA; Cohn SL; Reynolds CP
Clin Cancer Res; 2011 Nov; 17(21):6858-66. PubMed ID: 21908574
[TBL] [Abstract][Full Text] [Related]
13. Induction and intracellular localization of Nur77 dictate fenretinide-induced apoptosis of human liver cancer cells.
Yang H; Bushue N; Bu P; Wan YJ
Biochem Pharmacol; 2010 Apr; 79(7):948-54. PubMed ID: 19912993
[TBL] [Abstract][Full Text] [Related]
14. Combinational treatment with retinoic acid derivatives in non-small cell lung carcinoma in vitro.
Choi EJ; Whang YM; Kim SJ; Kim HJ; Kim YH
J Korean Med Sci; 2007 Sep; 22 Suppl(Suppl):S52-60. PubMed ID: 17923756
[TBL] [Abstract][Full Text] [Related]
15. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
Ohlmann CH; Jung C; Jaques G
Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines.
Kalemkerian GP; Slusher R; Ramalingam S; Gadgeel S; Mabry M
J Natl Cancer Inst; 1995 Nov; 87(22):1674-80. PubMed ID: 7473815
[TBL] [Abstract][Full Text] [Related]
17. Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines.
Zou CP; Kurie JM; Lotan D; Zou CC; Hong WK; Lotan R
Clin Cancer Res; 1998 May; 4(5):1345-55. PubMed ID: 9607596
[TBL] [Abstract][Full Text] [Related]
18. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.
Delia D; Aiello A; Lombardi L; Pelicci PG; Grignani F; Grignani F; Formelli F; Menard S; Costa A; Veronesi U
Cancer Res; 1993 Dec; 53(24):6036-41. PubMed ID: 8261419
[TBL] [Abstract][Full Text] [Related]
19. Fenretinide and its relation to cancer.
Ulukaya E; Wood EJ
Cancer Treat Rev; 1999 Aug; 25(4):229-35. PubMed ID: 10448131
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
